Neuroblastoma Clinical Trials

A listing of Neuroblastoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 32 clinical trials
Investigating Safety Tolerability Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours

A study to find out whether olaparib is safe and well tolerated when administered to children and adolescents with solid tumours

  • 16 views
  • 01 Aug, 2021
  • 20 locations
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor may not need

etoposide
mycn protein
ganglioneuroblastoma
doxorubicin
tumor cells
  • 265 views
  • 01 Aug, 2021
  • 122 locations
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

Children and adults diagnosed with high-risk neuroblastoma patients with primary refractory disease or incomplete response to salvage treatment in bone and/or bone marrow will be treated for up

colony stimulating factor
monoclonal antibodies
hu3f8
bone marrow procedure
high-risk neuroblastoma
  • 156 views
  • 23 Jul, 2021
  • 31 locations
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

This phase III trial studies iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive

catecholamines
vincristine
busulfan
ganglioneuroblastoma
high-risk neuroblastoma
  • 66 views
  • 31 Jul, 2021
  • 104 locations
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

An open-label, global, multi-center study to evaluate the safety and pharmacokinetics of venetoclax monotherapy, to determine the dose limiting toxicity (DLT) and the recommended Phase 2 dose (RPTD), and to assess the preliminary efficacy of venetoclax in pediatric and young adult participants with relapsed or refractory malignancies.

vincristine
venetoclax
decitabine
rituximab
topotecan
  • 263 views
  • 01 Aug, 2021
  • 46 locations
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphomas or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists …

cellular therapy
interleukins
total body irradiation
brainstem tumor
beta human chorionic gonadotropin
  • 997 views
  • 01 Aug, 2021
  • 114 locations
67Cu-SARTATE Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma

The aim of this study is to evaluate the safety and efficacy of 67Cu-SARTATE in pediatric patients with high-risk neuroblastoma.

renal function
combination chemotherapy
platelet count
high-risk neuroblastoma
neutrophil count
  • 0 views
  • 01 Aug, 2021
  • 5 locations
Clinical Trial of Arsenic Trioxide Combined Chemotherapy in the Treatment of Stage 4 Neuroblastoma

This clinical trial aims to evaluate the therapeutic effects and toxicity of chemotherapy combined with arsenic trioxide treating patients with recurrent or refractory stage 4 Neuroblastoma.

vincristine
metastatic neuroblastoma
cyclophosphamide
etoposide
  • 6 views
  • 01 Aug, 2021
  • 1 location
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

the blood and can detect and stick to cancer cells called neuroblastoma cells because they have a substance on the outside of the cells called GD2. For this study, the anti-GD2 antibody has been

cellular therapy
fludarabine
ganglioneuroblastoma
high-risk neuroblastoma
pulse oximetry
  • 16 views
  • 18 Jul, 2021
  • 1 location
9-ING-41 in Pediatric Patients With Refractory Malignancies.

9-ING-41 has anti-cancer clinical activity with no significant toxicity in adult patients. This Phase 1 study will study its efficacy in paediatric patients with advanced malignancies.

mibg
hematopoietic growth factors
topotecan
growth factor
iobenguane
  • 0 views
  • 01 Aug, 2021
  • 9 locations